Related Experiment Video
Updated: Dec 19, 2025

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Unveiling functional motions based on point mutations in biased signaling systems: A normal mode study on nerve
Pedro Túlio Resende-Lara1,2, David Perahia2, Ana Lígia Scott1
1Laboratório de Biologia Computacional e Bioinformática, Universidade Federal do ABC, Santo André, São Paulo, Brazil.
Abstract:
Many receptors elicit signal transduction by activating multiple intracellular pathways. This transduction can be triggered by a non-specific ligand, which simultaneously activates all the signaling pathways of the receptors. However, the binding of one biased ligand preferentially trigger one pathway over another, in a process called biased signaling. The identification the functional motions related to each of these distinct pathways has a direct impact on the development of new effective and specific drugs. We show here how to detect specific functional motions by considering the case of the NGF/TrkA-Ig2 complex. NGF-mediated TrkA receptor activation is dependent on specific structural motions that trigger the neuronal growth, development, and survival of neurons in nervous system. The R221W mutation in the ngf gene impairs nociceptive signaling. We discuss how the large-scale structural effects of this mutation lead to the suppression of collective motions necessary to induce TrkA activation of nociceptive signaling. Our results suggest that subtle changes in the NGF interaction network due to the point mutation are sufficient to inhibit the motions of TrkA receptors putatively linked to nociception. The methodological approach presented in this article, based jointly on the normal mode analysis and the experimentally observed functional alterations due to point mutations provides an essential tool to reveal the structural changes and motions linked to the disease, which in turn could be necessary for a drug design study.
Insights
Biased signaling, where ligands activate specific receptor pathways, is key for drug development. This study reveals how a specific mutation in NGF disrupts TrkA receptor motions, impairing nociceptive signaling and offering insights for new drug design.
Area of Science:
- Molecular Biology
- Biophysics
- Neuroscience
Background:
- Receptor signaling involves complex intracellular pathways.
- Biased signaling, triggered by specific ligands, preferentially activates certain pathways.
- Understanding these pathways is crucial for targeted drug development.
Purpose of the Study:
- To identify specific functional motions in receptor signaling.
- To investigate the impact of mutations on these motions using the NGF/TrkA-Ig2 complex as a model.
- To explore the link between structural changes, functional alterations, and disease.
Main Methods:
- Utilized normal mode analysis.
- Integrated experimental observations of functional alterations due to point mutations.
- Focused on the NGF/TrkA-Ig2 complex and the R221W mutation in the NGF gene.
Main Results:
- Demonstrated the detection of specific functional motions linked to distinct signaling pathways.
- Showed that the R221W mutation in NGF impairs nociceptive signaling by suppressing collective motions necessary for TrkA activation.
- Identified that subtle changes in the NGF interaction network can inhibit TrkA receptor motions associated with nociception.
Conclusions:
- The presented methodology effectively reveals structural changes and motions linked to disease.
- This approach provides a valuable tool for drug design studies targeting specific signaling pathways.
- Understanding mutation-induced alterations in receptor dynamics is essential for developing effective and specific therapeutics.
Related Concept Videos
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
MAPK Signaling Cascades
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

